Korean J Gastroenterol.  2004 Aug;44(2):59-65.

Gastrointestinal Carcinoid Tumor

Affiliations
  • 1Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. hyunchae@plaza.snu.ac.kr

Abstract

Carcinoid tumors originate from the neuroendocrine cells throughout the body and occur most frequently (74%) in the gastrointestinal tract. The clinical course is often indolent but can also be aggressive and resistant to therapy. Clinical manifestations are often vague or absent. Nevertheless, in approximately 10% of patients, the tumors secrete bioactive mediators which may engender various elements of characteristic carcinoid syndrome. In many instances, the neoplasms are detected incidentally at the time of surgery for other gastrointestinal disorders. The tendency for metastatic spread correlates with tumor size, and is substantially higher in lesions larger than 2.0 cm. Management of patients with carcinoid tumors requires an understanding of the disease process and a multimodality approach. Treatment consists of radical surgical excision of the tumor, although gastric (type I and II) and rectal carcinoids may be managed with local excision. However, advanced carcinoid tumor remains incurable.

Keyword

Neuroendocrine; Multimodality; Bioactive; Mediators; Surgical; Local; Excision; Metastatic

MeSH Terms

*Carcinoid Tumor/diagnosis/therapy
English Abstract
*Gastrointestinal Neoplasms/diagnosis/therapy
Humans
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr